Every material Form 8-K DuPont filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
DuPont de Nemours, Inc. reported third-quarter 2026 net sales of $1.9 billion and GAAP EPS from continuing operations of $1.24, exceeding its prior guidance. Driven by organic growth and strong operating leverage, management raised its full-year 2026 financial guidance.
Net sales of $1.9 billion increased 4% year-over-year, with organic sales up 5%.
GAAP EPS from continuing operations was $1.24, and adjusted EPS was $2.09 for the third quarter of 2026.
Full-year 2026 guidance was raised to approximately $7.19 billion in net sales and $7.47 to $7.52 in adjusted EPS.
The company completed a $250 million accelerated share purchase in the third quarter of 2026.
On September 9, 2026, DuPont, Chemours and Corteva entered a settlement with the State of North Carolina and 11 local entities to resolve PFAS-related claims, including claims tied to the Fayetteville Works facility and AFFF-related contamination. The settlement is subject to entry of orders dismissing the covered claims, and DuPont recorded a probable loss of about $125 million in the second quarter of 2026, which the press release says is materially covered by existing accruals.
Aggregate cash payment of $455 million to the plaintiffs, payable over 15 years, shared under the 2021 MOU; $18 million is attributed to PFAS contamination unrelated to Fayetteville Works.
DuPont recorded a probable loss of about $125 million in Q2 2026 within discontinued operations, before Qnity Electronics' reimbursement of 44% of DuPont's share.
DuPont and Corteva will establish a $135 million Reserve Fund, accessible only if Chemours fails to perform under its 2019 Consent Order with the State.
Future MOU escrow contributions, including the one due in September 2026, will be considered satisfied by the New Jersey and North Carolina settlement payments.
DuPont reported second quarter 2026 results with net sales of $1.8 billion, up 4%, and adjusted EPS of $1.88, up 48% from $1.27 a year earlier. The company raised its full-year 2026 guidance and said it intends to repurchase $250 million of shares in the third quarter, which points to higher earnings and cash returns for shareholders.
Net sales of $1,819 million rose 4% from $1,749 million; organic sales also rose 4%
GAAP EPS from continuing operations was $1.37, versus $0.17 a year earlier
Full-year 2026 adjusted EPS guidance midpoint raised to $7.24 per share; operating EBITDA midpoint raised to approximately $1.76 billion
Intent to repurchase $250 million of shares in the third quarter
DuPont reported first quarter 2026 net sales of $1.7 billion, up 4%, and GAAP earnings per share from continuing operations of $0.36, up from $0.19 a year earlier. The company also raised its full-year 2026 guidance and announced a $275 million accelerated share repurchase, which would return capital to shareholders.
Q1 2026 net sales of $1,681 million, up 4% from $1,612 million; organic sales up 2%
Adjusted EPS of $0.55 versus $0.36 a year earlier; GAAP EPS from continuing operations of $0.36 versus $0.19
Full-year 2026 adjusted EPS guidance of $2.35 to $2.40; full-year net sales guidance of $7,155 million to $7,215 million
Completed the Aramids business divestiture on April 1, 2026 and announced a $275 million accelerated share repurchase
DuPont de Nemours said director Luke Kissam resigned from its Board of Directors effective April 14, 2026, to become Chief Executive Officer of Corteva, Inc. The filing states the departure was not due to any disagreement with the company, and the board cut its size from eleven to ten seats.
Kissam tendered his resignation on April 13, 2026, effective April 14, 2026.
Resignation tied to his future appointment as CEO of Corteva, Inc.
No disagreement with the company on operations, policies or practices, per the filing.
DuPont reported fourth quarter and full year 2025 results, with Q4 net sales flat at $1.7 billion and a GAAP loss from continuing operations of $108 million, narrower than the $291 million loss a year earlier. For the full year, net sales rose 2% to $6.8 billion, GAAP income from continuing operations was $98 million, and adjusted EPS was $1.68, up from $1.45. The company also issued 2026 guidance calling for full year adjusted EPS of $2.25 to $2.30.
Q4 2025 adjusted EPS was $0.46, up 18%; GAAP EPS from continuing operations was $(0.27), versus $(0.70) a year earlier.
Q4 net sales were flat at $1.7 billion, with organic sales down 1%; about $30 million of order timing shifted into the third quarter.
Full year 2025 adjusted EPS was $1.68 versus $1.45; cash from continuing operations was $560 million, down from $765 million.
2026 guidance: full year net sales of $7.075 billion to $7.135 billion and adjusted EPS of $2.25 to $2.30; Q1 2026 adjusted EPS of about $0.48.
DuPont de Nemours appointed D.G. Macpherson, chairman and CEO of W.W. Grainger, to its Board of Directors effective January 20, 2026. The board determined he is independent under NYSE and SEC rules, and he will receive the standard compensation for non-employee directors.
Appointed to the board effective immediately on January 20, 2026
Macpherson has been CEO of W.W. Grainger since 2016 and chairman since 2017
Previously served as Grainger's COO and at Boston Consulting Group before joining Grainger in 2008
Filing states no arrangement or related-party transactions requiring disclosure
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DuPont filing is on SEC EDGAR ↗. 8-K briefs of other companies →